Literature DB >> 23731622

Increased body mass index makes an impact on brain white-matter integrity in adults with remitted first-episode mania.

C N Kuswanto1, M Y Sum1, G L Yang2, W L Nowinski2, R S McIntyre3, K Sim1.   

Abstract

BACKGROUND: Obesity is increasingly prevalent in bipolar disorder (BD) but data about the impact of elevated body mass index (BMI) on brain white-matter integrity in BD are sparse. Based on extant literature largely from structural magnetic resonance imaging (MRI) studies, we hypothesize that increased BMI is associated with decreased fractional anisotropy (FA) in the frontal, temporal, parietal and occipital brain regions early in the course of BD.
METHOD: A total of 26 euthymic adults (12 normal weight and 14 overweight/obese) with remitted first-episode mania (FEM) and 28 controls (13 normal weight and 15 overweight/obese) matched for age, handedness and years of education underwent structural MRI and diffusion tensor imaging scans.
RESULTS: There are significant effects of diagnosis by BMI interactions observed especially in the right parietal lobe (adjusted F(1,48) = 5.02, p = 0.030), occipital lobe (adjusted F(1,48) = 10.30, p = 0.002) and temporal lobe (adjusted F(1,48) = 7.92, p = 0.007). Specifically, decreased FA is found in the right parietal (F(1,48) = 5.864, p = 0.023) and occipital lobes (F(1,48) = 4.397, p = 0.047) within overweight/obese patients compared with normal-weight patients with FEM. Compared with overweight/obese controls, decreased FA is observed in right parietal (F(1,48) = 6.708, p = 0.015), temporal (F(1,48) = 10.751, p = 0.003) and occipital (F(1,48) = 9.531, p = 0.005) regions in overweight/obese patients with FEM.
CONCLUSIONS: Our findings suggest that increased BMI affects temporo-parietal-occipital brain white-matter integrity in FEM. This highlights the need to further elucidate the relationship between obesity and other neural substrates (including subcortical changes) in BD which may clarify brain circuits subserving the association between obesity and clinical outcomes in BD.

Entities:  

Mesh:

Year:  2013        PMID: 23731622     DOI: 10.1017/S0033291713000858

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  5 in total

1.  Altered spatiotemporal consistency of corticolimbic circuitry in euthymic pediatric bipolar disorder.

Authors:  Yongxin Guo; Jinfeng Wang; Qing Jiao; Weifang Cao; Dong Cui; Weijia Gao; Jianfeng Qiu; Linyan Su; Guangming Lu
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

2.  Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder.

Authors:  S L McElroy; D E Kemp; E S Friedman; N A Reilly-Harrington; L G Sylvia; J R Calabrese; D J Rabideau; T A Ketter; M E Thase; V Singh; M Tohen; C L Bowden; E E Bernstein; B D Brody; T Deckersbach; J H Kocsis; G Kinrys; W V Bobo; M Kamali; M G McInnis; A C Leon; S Faraone; A A Nierenberg; R C Shelton
Journal:  Acta Psychiatr Scand       Date:  2015-06-26       Impact factor: 6.392

3.  Diagnosis and body mass index effects on hippocampal volumes and neurochemistry in bipolar disorder.

Authors:  D J Bond; L E Silveira; E L MacMillan; I J Torres; D J Lang; W Su; W G Honer; R W Lam; L N Yatham
Journal:  Transl Psychiatry       Date:  2017-03-28       Impact factor: 6.222

Review 4.  Call to action regarding the vascular-bipolar link: A report from the Vascular Task Force of the International Society for Bipolar Disorders.

Authors:  Benjamin I Goldstein; Bernhard T Baune; David J Bond; Pao-Huan Chen; Lisa Eyler; Andrea Fagiolini; Fabiano Gomes; Tomas Hajek; Jessica Hatch; Susan L McElroy; Roger S McIntyre; Miguel Prieto; Louisa G Sylvia; Shang-Ying Tsai; Andrew Kcomt; Jess G Fiedorowicz
Journal:  Bipolar Disord       Date:  2020-06-08       Impact factor: 6.744

Review 5.  Elevated Brain Glutamate Levels in Bipolar Disorder and Pyruvate Carboxylase-Mediated Anaplerosis.

Authors:  Jun Shen; Jyoti Singh Tomar
Journal:  Front Psychiatry       Date:  2021-02-23       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.